ID

34576

Descripción

Non-interventional Local Study on Prescription Behavior of Anticoagulation Therapy in Secondary Stroke Prevention in Atrial Fibrillation Patients; ODM derived from: https://clinicaltrials.gov/show/NCT01925755

Link

https://clinicaltrials.gov/show/NCT01925755

Palabras clave

  1. 19/1/19 19/1/19 -
  2. 28/9/20 28/9/20 -
Titular de derechos de autor

see on clinicaltrials.gov

Subido en

19 de enero de 2019

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0

Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Stroke, NCT01925755

Eligibility Stroke, NCT01925755

  1. StudyEvent: Eligibility
    1. Eligibility Stroke, NCT01925755
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
male and female patients ≥ 18 years old who start treatment with rivaroxaban
Descripción

ID.1

Tipo de datos

boolean

non-valvular atrial fibrillation is documented in patients' file
Descripción

ID.2

Tipo de datos

boolean

prior tia/stroke history
Descripción

ID.3

Tipo de datos

boolean

tia - more than 72 hours after documented tia
Descripción

ID.4

Tipo de datos

boolean

more than 2 weeks after non-hemorrhagic stroke
Descripción

ID.5

Tipo de datos

boolean

written informed consent
Descripción

ID.6

Tipo de datos

boolean

Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
contraindications for use of xarelto® in accordance with approved product label
Descripción

ID.7

Tipo de datos

boolean

previous thromboprophylaxis treatment with anticoagulants prior toby reason of stroke
Descripción

ID.8

Tipo de datos

boolean

/ tia prevention
Descripción

ID.9

Tipo de datos

boolean

any reasons of medical and non-medical character, which in the opinion of the physician can hamper patient participation in nis
Descripción

ID.10

Tipo de datos

boolean

Similar models

Eligibility Stroke, NCT01925755

  1. StudyEvent: Eligibility
    1. Eligibility Stroke, NCT01925755
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
male and female patients ≥ 18 years old who start treatment with rivaroxaban
boolean
ID.2
Item
non-valvular atrial fibrillation is documented in patients' file
boolean
ID.3
Item
prior tia/stroke history
boolean
ID.4
Item
tia - more than 72 hours after documented tia
boolean
ID.5
Item
more than 2 weeks after non-hemorrhagic stroke
boolean
ID.6
Item
written informed consent
boolean
Item Group
C0680251 (UMLS CUI)
ID.7
Item
contraindications for use of xarelto® in accordance with approved product label
boolean
ID.8
Item
previous thromboprophylaxis treatment with anticoagulants prior toby reason of stroke
boolean
ID.9
Item
/ tia prevention
boolean
ID.10
Item
any reasons of medical and non-medical character, which in the opinion of the physician can hamper patient participation in nis
boolean

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial